当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析

健帆生物

(300529)

  

流通市值:136.33亿  总市值:211.18亿
流通股本:5.21亿   总股本:8.08亿

健帆生物(300529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润2.84亿元,每股收益0.35元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益323362.12万元,未分配利润228868.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产585363.98万元,负债262001.85万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入744,336,658.851,922,348,169.841,485,982,0861,012,143,747.49
营业总成本421,939,785.991,420,642,392.891,013,972,529.49705,759,297.71
营业利润348,716,883.42543,819,217.95515,129,256.21339,523,622.35
利润总额339,934,406.15521,020,064.38498,889,014329,064,388.32
净利润283,928,180.04425,723,151.05420,436,301.43275,203,101.22
其他综合收益-26,930,819.400
综合收益总额283,928,180.04452,653,970.45420,436,301.43275,203,101.22
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,599,004,272.763,311,841,550.33,336,267,839.153,490,880,397.43
非流动资产合计2,254,635,509.872,231,460,090.72,159,849,230.352,145,930,423.84
资产总计5,853,639,782.635,543,301,6415,496,117,069.55,636,810,821.27
流动负债合计1,202,008,372.32829,420,061.99819,540,750.47938,384,408.45
非流动负债合计1,418,010,165.141,561,007,053.641,553,920,304.151,446,783,903.48
负债合计2,620,018,537.462,390,427,115.632,373,461,054.622,385,168,311.93
归属于母公司股东权益合计3,229,059,708.623,147,475,025.763,109,706,337.723,237,779,180.54
股东权益合计3,233,621,245.173,152,874,525.373,122,656,014.883,251,642,509.34
负债和股东权益合计5,853,639,782.635,543,301,6415,496,117,069.55,636,810,821.27
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计902,676,285.022,523,492,517.541,888,534,993.441,285,866,649.21
经营活动现金流出小计395,581,038.591,606,748,650.651,298,492,567.28849,168,162.4
经营活动产生的现金流量净额507,095,246.43916,743,866.89590,042,426.16436,698,486.81
投资活动现金流入小计424,597,351.0612,604,014.512,020,714.59,276,922
投资活动现金流出小计1,263,865,172.16262,253,333.78100,962,321.9872,542,074.03
投资活动产生的现金流量净额-839,267,821.1-249,649,319.28-88,941,607.48-63,265,152.03
筹资活动现金流入小计251,826,834.7893,213,486.28864,412,805.41576,160,112.87
筹资活动现金流出小计345,035,364.591,345,124,776.651,203,393,901810,893,929.16
筹资活动产生的现金流量净额-93,208,529.89-451,911,290.37-338,981,095.59-234,733,816.29
汇率变动对现金及现金等价物的影响-48,879.2911,394.79-18,550.06-29,132.91
现金及现金等价物净增加额-425,429,983.85215,194,652.03162,101,173.03138,670,385.58
期末现金及现金等价物余额2,316,113,304.032,741,543,287.882,688,449,808.882,665,019,021.43
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国金证券袁维,何冠洲1.231.822.322024-04-25
TOP↑